252 related articles for article (PubMed ID: 14605086)
1. Refractory sarcoidosis responding to infliximab.
Roberts SD; Wilkes DS; Burgett RA; Knox KS
Chest; 2003 Nov; 124(5):2028-31. PubMed ID: 14605086
[TBL] [Abstract][Full Text] [Related]
2. Refractory vertebral sarcoidosis responding to infliximab.
Garg S; Garg K; Altaf M; Magaldi JA
J Clin Rheumatol; 2008 Aug; 14(4):238-40. PubMed ID: 18766126
[TBL] [Abstract][Full Text] [Related]
3. [Sarcoidosis: changing insights in therapy].
Kamphuis LS; van Laar JA; Kuijpers RW; Missotten T; Thio HB; van Hagen PM
Ned Tijdschr Geneeskd; 2010; 154(47):A1685. PubMed ID: 21118599
[TBL] [Abstract][Full Text] [Related]
4. Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients.
Riancho-Zarrabeitia L; Calvo-Río V; Blanco R; Mesquida M; Adan AM; Herreras JM; Aparicio Á; Peiteado-Lopez D; Cordero-Coma M; García Serrano JL; Ortego-Centeno N; Maíz O; Blanco A; Sánchez-Bursón J; González-Suárez S; Fonollosa A; Santos-Gómez M; González-Vela C; Loricera J; Pina T; González-Gay MA
Semin Arthritis Rheum; 2015 Dec; 45(3):361-8. PubMed ID: 26092330
[TBL] [Abstract][Full Text] [Related]
5. Treatment of sarcoidosis with infliximab.
Doty JD; Mazur JE; Judson MA
Chest; 2005 Mar; 127(3):1064-71. PubMed ID: 15764796
[TBL] [Abstract][Full Text] [Related]
6. Progressive cutaneous sarcoidosis responding to anti-tumor necrosis factor-alpha therapy.
Mallbris L; Ljungberg A; Hedblad MA; Larsson P; Ståhle-Bäckdahl M
J Am Acad Dermatol; 2003 Feb; 48(2):290-3. PubMed ID: 12582407
[TBL] [Abstract][Full Text] [Related]
7. Infliximab for refractory sarcoidosis.
Baughman RP; Lower EE
Sarcoidosis Vasc Diffuse Lung Dis; 2001 Mar; 18(1):70-4. PubMed ID: 11354550
[TBL] [Abstract][Full Text] [Related]
8. Refractory retinal vasculitis due to sarcoidosis successfully treated with infliximab.
Cruz BA; Reis DD; Araujo CA;
Rheumatol Int; 2007 Oct; 27(12):1181-3. PubMed ID: 17520259
[TBL] [Abstract][Full Text] [Related]
9. Isolated renal sarcoidosis: a rare presentation of a rare disease treated with infliximab.
Ahmed MM; Mubashir E; Dossabhoy NR
Clin Rheumatol; 2007 Aug; 26(8):1346-9. PubMed ID: 16850114
[TBL] [Abstract][Full Text] [Related]
10. Refractory neurosarcoidosis responding to infliximab.
Pettersen JA; Zochodne DW; Bell RB; Martin L; Hill MD
Neurology; 2002 Nov; 59(10):1660-1. PubMed ID: 12451224
[No Abstract] [Full Text] [Related]
11. Tumour necrosis factor in sarcoidosis and its potential for targeted therapy.
Baughman RP; Iannuzzi M
BioDrugs; 2003; 17(6):425-31. PubMed ID: 14614765
[TBL] [Abstract][Full Text] [Related]
12. Infliximab for treating sarcoidosis patients, Portuguese experience.
Aguiar M; Marçal N; Mendes AC; Bugalho de Almeida A
Rev Port Pneumol; 2011; 17(2):85-93. PubMed ID: 21477572
[TBL] [Abstract][Full Text] [Related]
13. Refractory chronic cutaneous sarcoidosis responsive to dose escalation of TNF-alpha antagonists.
Thielen AM; Barde C; Saurat JH; Laffitte E
Dermatology; 2009; 219(1):59-62. PubMed ID: 19468200
[TBL] [Abstract][Full Text] [Related]
14. Long term follow-up of infliximab efficacy in pulmonary and extra-pulmonary sarcoidosis refractory to conventional therapy.
Russell E; Luk F; Manocha S; Ho T; O'Connor C; Hussain H
Semin Arthritis Rheum; 2013 Aug; 43(1):119-24. PubMed ID: 23332903
[TBL] [Abstract][Full Text] [Related]
15. Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis.
Sakkat A; Cox G; Khalidi N; Larche M; Beattie K; Renzoni EA; Morar N; Kouranos V; Kolb M; Hambly N
Respir Res; 2022 Mar; 23(1):54. PubMed ID: 35264154
[TBL] [Abstract][Full Text] [Related]
16. [Nasosinusal and cervical sarcoidosis: a case series of three patients and literature review].
Hermet M; le Guenno G; Rieu V; Philippe P; Ruivard M
Rev Med Interne; 2012 Jan; 33(1):46-9. PubMed ID: 21601318
[TBL] [Abstract][Full Text] [Related]
17. Successful long-term management of refractory cutaneous and upper airway sarcoidosis with periodic infliximab infusion.
Rosen T; Doherty C
Dermatol Online J; 2007 Jul; 13(3):14. PubMed ID: 18328208
[TBL] [Abstract][Full Text] [Related]
18. Steroid-resistant sarcoidosis: is antagonism of TNF-alpha the answer?
Denys BG; Bogaerts Y; Coenegrachts KL; De Vriese AS
Clin Sci (Lond); 2007 Mar; 112(5):281-9. PubMed ID: 17261090
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Tolerance of Anti-Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis: A French Study of 46 Cases.
Heidelberger V; Ingen-Housz-Oro S; Marquet A; Mahevas M; Bessis D; Bouillet L; Caux F; Chapelon-Abric C; Debarbieux S; Delaporte E; Duval-Modeste AB; Fain O; Joly P; Marchand-Adam S; Monfort JB; Noël N; Passeron T; Ruivard M; Sarrot-Reynauld F; Verrot D; Bouvry D; Fardet L; Chosidow O; Sève P; Valeyre D
JAMA Dermatol; 2017 Jul; 153(7):681-685. PubMed ID: 28564695
[TBL] [Abstract][Full Text] [Related]
20. Successful tumor necrosis factor alpha blockade treatment in therapy-resistant sarcoidosis.
Ulbricht KU; Stoll M; Bierwirth J; Witte T; Schmidt RE
Arthritis Rheum; 2003 Dec; 48(12):3542-3. PubMed ID: 14674007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
